Category

Weekly Emails

Time-restricted eating: efficacy versus effectiveness

What happens when people are prescribed a treatment vs what happens when people take the treatment are two different questions.

Topo Chico

Am I going to throw out my current stockpile of Topo Chico?

A few things worth sharing: 10-04-2020

Longevity in mice; The wonders of F1.

Colorectal cancer screening

When I learned about Chadwick Boseman’s death from colorectal cancer (CRC) at the age of 43 a few weeks ago, it broke my heart.

I need your help!

How can we take some of the bespoke insights we provide to our relatively few patients and deliver them on a larger scale?

A few things worth sharing: 09-13-2020

The Lost Years and Last Days of David Foster Wallace.

Randomized controlled trials: when the gold standard leaves you with fool’s gold

If I told you that I read a randomized double-blinded placebo-controlled trial conducted over 5 years and carried out in over 18,000 participants, is there any scenario under which you would not believe it to be an excellent trial?

A few things worth sharing: 08-30-2020

Shitty first drafts and accelerating fasts.

Normative errors and Surgisphere

Last month, the New York Times profiled Dr. Sapan Desai, founder of Surgisphere, the company that supplied the data for two recently retracted studies.

A few things worth sharing: 08-16-2020

I’m doing something a little different for this week’s email and highlighting a couple of things I thought were worth sharing.

Facebook icon Twitter icon Instagram icon Pinterest icon Google+ icon YouTube icon LinkedIn icon Contact icon